Purple Biotech Says IM1240 Abstract Selected for Oral Presentation
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
China's STAR 50 Index Opens 3% Lower, Hits 14-Month Low
M impact | EQUITY | Oct 30, 2026, 01:26 AM UTC
Nikkei Stock Average Falls 2.8% to 62,828.28
M impact | EQUITY | Oct 30, 2026, 01:26 AM UTC
Virgin Australia Warns Industrial Action May Delay Sydney Airport Screening
L impact | EQUITY | Oct 30, 2026, 01:26 AM UTC
Murray Cod Australia Posts Q1 FY27 Sales Volume of 175.9 Tonnes
L impact | EQUITY | Oct 30, 2026, 01:26 AM UTC
Shenzhen Composite Opens 2.1% Lower at 2069.73
M impact | EQUITY | Oct 30, 2026, 01:26 AM UTC
Daewoo Engineering & Construction Wins 275 Billion Won Order
M impact | EQUITY | Oct 30, 2026, 01:26 AM UTC